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Policy options to reduce population salt intake
High dietary salt has detrimental effects on blood pressure and cardiovascular outcomes. The
question, say Francesco Cappuccio and colleagues, is not whether to reduce salt intake but how
to do so. With the upcoming United Nations High Level Meeting on non-communicable diseases in
mind, they make the case for population level policy interventions.
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Blood pressure and cardiovascular
disease
Raised blood pressure is the dominant cause of death and
disability in adults worldwide,1 responsible for approximately
50% of deaths from coronary heart disease and over 60% of
those from stroke. The risk of cardiovascular disease increases
with increasing blood pressure,2 and causality is supported by
randomised controlled clinical trials, in which lowering blood
pressure over five years reduces cardiovascular disease by
approximately the amount predicted from larger observational
studies.3 But the majority of cardiovascular disease events
attributable to blood pressure occur in people with untreated
“normal” pressure (about 130/80mmHg), with additional events
occurring even with blood pressure levels down to 115/75 mm
Hg. 2 Even a small downward shift in the distribution of blood
pressure in the whole population would achieve a large drop in
cardiovascular disease.2
Evidence relating salt to blood pressure
Evidence from a very wide variety of studies shows a consistent
direct relation between salt intake and blood pressure. A 4.6 g
reduction in daily dietary intake of salt (equivalent to a 1840
mg reduction in daily sodium) decreases blood pressure by about
5.0/2.7 mm Hg in individuals with hypertension and by 2.0/1.0
mm Hg in normotensive people.4 Randomised controlled trials
have consistently shown dose-response effects.5 The blood
pressure lowering effect of reducing salt intake is effective in
men and women, in all ethnic groups, in all age groups, and all
starting blood pressures.
Population based interventions indicate that when salt intake is
reduced, blood pressure in the community falls. An intervention
study in two Portuguese villages over two years achieved a
difference between intervention and control villages of about
50% in salt intake and a difference of 13/6 mm Hg in blood
pressure.6 A randomised community based intervention trial in
villages in northeastern Japan, which tested the effects of dietary
counselling for one year, reduced mean salt intake by 2.3 g/day
(920 mg of sodium) as measured by 24 h urinary sodium, and
was associated with a decrease of 3.1 mm Hg in systolic blood
pressure.7 Citizens in most countries eat salt far in excess of
healthy physiological requirements (about 1 g per day).
Evidence relating salt to cardiovascular
disease
No randomised controlled trials have studied the effect of
reducing the salt intake of populations on cardiovascular
disease—the ethical and methodological problems with such
trials are similar to those with trials involving tobacco and
obesity8—but the link is strong and is now accepted. In cohort
studies, a 5 g per day higher salt intake (2000 mg of sodium) is
associated with a 17% greater risk of total cardiovascular
disease, and, crucially a 23% greater risk of stroke.9
Since the 1970s, Finland has aimed to reduce the population’s
salt intake10 by collaboration with the food industry to develop
food products with reduced salt and by raising awareness among
consumers. Over 30 years salt intake has reduced by a third (6
g per person per day). Systolic blood pressure fell by over 10
mmHg, while mortality from stroke and coronary heart disease
decreased 75-80%, with an increase of five to six years in life
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expectancy.10 Similarly, in Japan, a government campaign to
reduce salt intake saw a fall from 13.5 g/day to 12.1 g/day (from
5400 mg to 4840 mg sodium) in a decade. This was associated
with a substantial reduction in stroke mortality,11 despite
increases in the population’s fat intake, cigarette smoking,
alcohol consumption, and body mass index.
The economic imperative
All countries need to satisfy stringent cost effectiveness criteria
within a general climate of ageing populations, escalating
healthcare demands, and recently reduced financial resources.
Several economic modelling studies have assessed the health
effects and financial cost of reducing population salt intake.
Despite methodological differences, they all have consistently
shown that a reduction in salt intake is associated with
substantial cost savings (see webtable and web referencesw1-w12).
For example, in the United States, a mean population salt
reduction of 3 g per day would result in an estimated annual
gain of 194 000-392 000 quality adjusted life years (QALYs),
a measure of added healthy life, and savings of $10bn to $24bn
(£6-15bn, €7-17bn) in healthcare costs.w11 This represents a
$6-12 return on investment for each dollar spent on the
regulatory programme. Cost savings are also estimated for a
reduction in salt intake of 15% in low and middle income
countries, with 13.8 million deaths averted over 10 years at an
initial cost of less than $0.40 per person per year.w5
The prevention imperative
Unsurprisingly, the prevention of cardiovascular disease is now
agreed as a top priority for action worldwide.12 Among the five
priority interventions, reduction of populations’ salt intake is
listed as second after global tobacco control. It is estimated that
a 15% reduction in salt intake would avert 8.5 million deaths
over 10 years worldwide.
The global goal set byWHO is to reduce salt intake to less than
5 g (2000 mg of sodium) per person per day by 2025,12 with
some countries aiming for even lower levels in the longer term
(table 1).w13-w20 Progress towards this target could begin through
mass media campaigns and reformulation of existing and new
food products by industry. Since in most developed economies
the majority of dietary salt is added during commercial food
production, government regulation will also be needed.12 13
Many countries have committed themselves to salt reduction
initiatives, often led by government, sometimes led by
non-governmental organisations, but rarely led by industry (table
2).14 In 2004 the British government, through the Food Standards
Agency, started a programme of population salt reduction
through a media campaign to increase public awareness and
demand for change, engagement with the food industry on a
voluntary basis to set targets for sodium content in foods, and
to obtain reformulation of many common food categories, and
repeated national surveys using 24 h urine collections to monitor
intake.Ministers also proposed legislation if the industry refused
to make reductions voluntarily. As a result the mean salt intake
in the UK fell from 9.5 g (3800 mg sodium) per day in 2001 to
8.6 g (3440mg sodium) per day in 2008. In England andWales,
the government target is now 6 g (2400 mg sodium) per day by
2012, sadly remaining higher than the target of 4 g (1600 mg
sodium) per day achieved in the USDASH trial and of 3 g (1200
mg sodium) recommended by NICE by 2025.15 A reduction of
3 g per day in salt intake would result in a blood pressure fall
of at least 2.5/1.4 mmHg.15 This would reduce strokes by about
12-14% and coronary heart disease by 9-10%,9 15 equivalent to
approximately 6500-8000 deaths from stroke and 7500-12 000
deaths from coronary heart disease per year.15
In the United States, a reduction in salt intake of 3 g per day
would reduce the annual number of new cases of cardiovascular
disease by approximately 10% (around 60 000-120 000 fewer
cases of coronary heart disease, 32 000-66 000 strokes, and 54
000-99 000 heart attacks) with a corresponding reduction in all
cause mortality.w11 The expected reductions in vascular events
would be comparable with those currently projected for
interventions targeting tobacco, obesity, or primary prevention
with statins and antihypertensives.w5
Changing salt policies and perceived
barriers
As with tobacco, some vested interests in the salt and food
industries are fighting a rearguard action. The salt industry is
reluctant to facilitate a reduction in salt intake across
populations, but not because their major market is in food; less
than 10% of the salt sold worldwide enters the food chain. Yet
the use of salt in food is indirectly a source of revenue for food
and beverage manufacturers more widely. High salt intake
downregulates taste buds for saltiness, and makes food more
palatable, thus increasing demand. Salt in meat products, in
conjunction with other water binding chemicals, increases the
amount of water that can be bound into the meat, increasing
weight by up to 20% at no cost. High salt intake increases thirst
and demand for sugary drinks.10 These increase calorie intake,
particularly in younger people who are major consumers, thus
contributing to obesity.16
The UK experience indicates that in the early stages of a salt
reduction programme it is possible to take 5-15% of the salt out
of a product gradually without noticeable change in flavour,
sales, or complaints about taste. As salt intake falls, the salt taste
receptors in themouth adapt and becomemore sensitive to lower
concentrations of salt within months.17 Once salt intake is
reduced, people prefer the taste of food with less salt.18
Reports of paradoxical increases in cardiovascular risk in those
on a low sodium intake have recently sparked some debate.w21-w24
However, these studies are seriously flawed.w25-w28
The International Council for the Control of Iodine Deficiency
Disorders estimates that about 1.5 billion people worldwide live
in areas of iodine deficiency. In 1996, in conjunction withWHO
and Unicef, they started a universal salt iodisation programme,
using salt as a vehicle to deliver supplementary iodine in the
diet. If salt intake is reduced, these policies will remain
compatible, cost effective, and of great public health benefit, if
the level of iodine fortification can be adjusted to changing
sodium intake.
Various policy interventions are currently being tested or
implemented worldwide through national and international
initiatives (table 3).14 International schemes have led to high
level agreements among many governments for the
implementation of national programmes to reduce population
dietary salt for the prevention of cardiovascular disease. Salt
substitution policies are being tested in China, where this
alternative approach might be feasible. However, a regulatory
approach is both necessary and acceptable,13 as demonstrated
in Finland. This is more effective and cost effective than the
voluntary approach alone.w12
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Conclusions
Health policy makers and governments have to decide how best
to reduce population salt intake at a population level, to save
most lives and public money in shrinking economies; likewise,
in low and middle income countries with very limited budgets,
how best to afford cheaper and effective planning to prevent,
ameliorate, and control their rapidly increasing burden of
non-communicable diseases.
Changing personal behaviour and choice alone is not an effective
or realistic option when the majority of salt is added to food
before it is sold and food marketing relies on taste. Furthermore,
the commercial addition of salt to food is becoming a global
trend as the worldwide food economy changes. A four pronged
approach is therefore required and should form the base for a
comprehensive policy:
• Communication—establishing and evaluating public
awareness campaigns
• Reformulation—setting progressive salt targets for
reformulating existing processed food and engaging with
the food industry in setting standards for new foods
• Monitoring—surveying population salt intake, progress of
reformulation, and effectiveness of communication
• Regulation—engagement with industry, including
regulation, to create a level playing field so as not to
disadvantage more enlightened and progressive companies
The huge responsibility of food manufacturers in contributing
to the epidemic of cardiovascular diseasemust be acknowledged,
and prevention implemented through food reformulation and
effective voluntary, market intervention, or mandatory action
throughout the industry.19Civil society, governments, academia,
and health organisations all have a part to play. Denial and
procrastination will be costly in terms of both avoidable illness
and expenses.
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Tables
Table 1| Population dietary salt targets set worldwide
Targets for daily salt intake (g per person per
day)OrganisationCountry/region
5WHOWorldwide
4% reduction/year over 4 years (by 2012)EC High Level groupEurope
6DACHAustria
6GovernmentBelgium
5GovernmentBulgaria
5GovernmentCyprus
5GovernmentCzech Republic
5GovernmentDenmark
6 (men), 5 (women)GovernmentEstonia
7 (men), 6 (women)GovernmentFinland
8GovernmentFrance
6DACHGermany
5GovernmentGreece
5GovernmentHungary
7 (men), 6 (women)Nordic NutritionIceland
6 (by 2010)GovernmentIreland
6INRANItaly
5GovernmentLatvia
5GovernmentLithuania
6IndustryNetherlands
5GovernmentNorway
6GovernmentPoland
6GovernmentPortugal
5GovernmentRomania
5GovernmentSlovenia
5GovernmentSpain
7 (men), 6 (women)Nordic NutritionSweden
8GovernmentSwitzerland
6 (by 2015), 3 (by 2025)GovernmentUK
5 (by 2025)PAHO/WHOAmericas
6GovernmentArgentina
6GovernmentBarbados
5GovernmentBrazil
5.75 (by 2016)GovernmentCanada
5GovernmentChile
5GovernmentUruguay
5.8GovernmentUSA
Australasia
6NGOAustralia
5GovernmentFiji
6NGONew Zealand
5GovernmentSingapore
Asia
6NGOChina
6GovernmentIndonesia
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Table 1 (continued)
Targets for daily salt intake (g per person per
day)OrganisationCountry/region
6NGOJapan
EC=European Commission, DACH=D, Germany, A, Austria, CH, Switzerland, INRAN= National Research Institute for Food and Nutrition, PAHO=Pan American
Health Organization, NGO=non-governmental organisation. Source references available on bmj.comw13-w20
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Table 2| Worldwide policy interventions and implementation strategies to reduce dietary salt intake in populations
Consumer
educationFood reformulation
Monitoring
ongoing
Documented
consumer
behavioursSalt in food
Documented baseline
levels of salt intake (g per
person per day)LeadershipCountry/Region
Europe
YesVoluntaryYesYesYes11.0*GovernmentBelgium
VoluntaryYesYes12.0†GovernmentBulgaria
11.0-12.0†GovernmentCzech Republic
YesVoluntaryYes ‡YesGovernmentCyprus
YesVoluntaryYesYes7.0-11.0*GovernmentDenmark
Yes (NGO)VoluntaryYesYes7.6-10.0*GovernmentFinland
YesVoluntaryYesYes8.4†GovernmentFrance
Yes‡GovernmentGeorgia
Yes‡VoluntaryYesYes‡Yes16.0-18.0†GovernmentHungary
YesVoluntaryYesYesYes7.4-10.4*GovernmentIreland
VoluntaryYesYes‡10.8†GovernmentItaly
Yes‡VoluntaryYesYes‡YesGovernmentLatvia
Yes‡Voluntary11.0†GovernmentLithuania
Yes (NGO)VoluntaryYesYesYes7.6-9.7*IndustryNetherlands
Yes‡VoluntaryYes‡10.0†GovernmentNorway
Yes‡VoluntaryGovernmentPoland
YesMandatory‡11.9†GovernmentPortugal
Yes‡VoluntaryYesYes‡Yes9.9-13.0*GovernmentSlovenia
YesVoluntaryYes‡8.4-11.5*GovernmentSpain
10.0-12.0†GovernmentSweden
Yes‡Voluntary‡YesYes‡8.1-10.6*GovernmentSwitzerland
YesVoluntaryYesYesYes9.5*GovernmentUK
YesYesGovernmentUkraine
Americas
Mandatory‡YesYes‡Yes12.5†GovernmentArgentina
YesVoluntaryYesYes12.0-15.0GovernmentBarbados
VoluntaryYesYes9.6†GovernmentBrazil
Yes (NGO)VoluntaryYesYesYes7.8†GovernmentCanada
YesVoluntaryYes10.0†GovernmentChile
Yes‡Yes‡Yes‡7.0†GovernmentCosta Rica
10.0†GovernmentEcuador
19.0†GovernmentGuatemala
Voluntary‡YesYes‡GovernmentMexico
Yes (NGO)VoluntaryYesYes8.6†GovernmentUnited States
Australasia
YesVoluntaryYesYesYes6.5-12.0*NGOAustralia
YesVoluntaryYesYes‡Yes‡5.2-5.4†GovernmentFiji
Yes (NGO)VoluntaryYes‡Yes‡6.4†NGOMalaysia
Yes (NGO)VoluntaryYesYesYes5.4-7.6†NGONew Zealand
Yes‡GovernmentPhilippines
YesVoluntaryYes‡Yes8.8†GovernmentSingapore
Yes‡Yes‡GovernmentThailand
Yes‡Yes‡GovernmentVietnam
Asia
Yes‡Yes‡GovernmentBangladesh
Yes12.0†NGOChina
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Table 2 (continued)
Consumer
educationFood reformulation
Monitoring
ongoing
Documented
consumer
behavioursSalt in food
Documented baseline
levels of salt intake (g per
person per day)LeadershipCountry/Region
Yes‡Yes‡GovernmentIndia
Yes‡GovernmentIran
Yes (NGO)Yes13.2†NGOJapan
Yes‡GovernmentKuwait
Yes‡YesYesGovernmentSouth Korea
Africa
Yes‡YesGovernmentSouth Africa
NGO=non-governmental organisation.
*24 h urine.
†Dietary survey.
‡Planned.
Source references available on bmj.com.w13-w20
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Table 3| Policy options for reduction in population salt intake
Likely salt reduction (per person
per day)SynergiesEvidence basePolicy options
Negligible–Primary care in UKProfessional education and health
promotion
0.1 g*Politically popularUK, New York CitySocial marketing
0.5 g†Will also benefit fat and sugarFinland, European CommunityLabelling
1 g‡Will also benefit fat and sugarFinland, UKProduct reformulation
Not reported–ChinaSubstitution
2 g†Consistent with fat and sugar taxFinland, New York CityTaxation
3 g†Greatest benefit in deprived
groups—reduce inequalities
Finland, Belgium and Italy (bread), New
York City
Regulation and marketing control
*Estimated, no data available.
†Data from Finland.
‡Data from Finland and Food Standards Agency of England and Wales.
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